GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 97 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2016. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $676,000 | -82.0% | 19,501 | -77.6% | 0.02% | -58.5% |
Q4 2020 | $3,764,000 | -38.9% | 86,915 | -22.2% | 0.04% | -65.3% |
Q3 2020 | $6,162,000 | +468.5% | 111,745 | +49.0% | 0.12% | +237.1% |
Q4 2016 | $1,084,000 | -16.2% | 75,000 | +87.5% | 0.04% | -12.5% |
Q4 2015 | $1,293,000 | – | 40,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 460,000 | $14,872,000 | 13.19% |
VHCP Management II, LLC | 141,611 | $4,578,000 | 3.76% |
Perceptive Advisors | 1,186,630 | $38,363,000 | 2.84% |
RTW INVESTMENTS, LP | 175,156 | $5,663,000 | 1.87% |
Casdin Capital, LLC | 65,000 | $2,101,000 | 1.86% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,163,811 | $37,626,000 | 1.52% |
RA Capital Management | 457,142 | $14,779,000 | 1.46% |
VHCP Management, LLC | 60,691 | $1,962,000 | 1.19% |
Iguana Healthcare Management, LLC | 110,000 | $3,556,000 | 1.17% |
Partner Investment Management, L.P. | 15,634 | $505,000 | 0.83% |